Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors (Q34556386)

3 August 2017

Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors (English)

1 reference

3 August 2017

Fujino H

1

1 reference

3 August 2017

Saito T

2

1 reference

3 August 2017

Tsunenari Y

3

1 reference

3 August 2017

Kojima J

4

1 reference

3 August 2017

Sakaeda T

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

3 August 2017

1 reference

3 August 2017

34

1 reference

3 August 2017

11-12

1 reference

3 August 2017

961-971

1 reference

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

3 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

The effect of fluconazole on the pharmacokinetics of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Clinical pharmacokinetics of cerivastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Pharmacological interactions of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400015319

10.1080/00498250400015319

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference